The chemokine receptor‐like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling
Abstract
BACKGROUND AND PURPOSE: Apelin and Elabela are endogenous ligands of the apelin receptor (apelin receptor/APJ), a GPCR involved in cardiovascular regulation and body fluid homeostasis. The human receptor contains a conserved disulfide bridge linking the N-terminal domain to extracellular loop 3 (ECL3) via Cys19 and Cys281, forming a structural constraint analogous to a fourth extracellular loop ('ECL4'). In the chemokine receptor family, this motif plays a critical role in ligand engagement and receptor activation. EXPERIMENTAL APPROACH: The functional role of this disulfide bridge was investigated using site-directed mutagenesis (Cys19Ala and Cys281Ala), plasmon waveguide resonance binding assays and BRET-based biosensors to monitor Gαi activation and β-arrestin-2 recruitment. KEY RESULTS: Disruption of the disulfide bridge did not affect receptor surface expression but markedly impaired binding of apelin fragments (pE13F and K17F), leading to reduced Gαi signalling and β-arrestin-2 recruitment. In contrast, binding of the Elabela fragment K22P and the subsequent apelin receptor signalling activation were largely preserved. Antagonist antibodies (JN241 and JN241-Fc) retained activity, whereas the agonist antibody JN241-9-Fc showed strongly reduced efficacy for the mutated receptors. CONCLUSION AND IMPLICATIONS: The N-terminal/ECL3 disulfide bridge is a critical structural determinant for apelin binding and apelin receptor activation but is less critical for Elabela signalling, supporting distinct modes of ligand engagement. Antibody-mediated agonism is particularly sensitive to alterations of « ECL4 » without affecting its binding, suggesting that this structural constraint is required for optimal apelin receptor activation. The apelin receptor shares functional similarities with the chemokine receptors with respect to this.
Related
- Chemokine CXCL12 Mediates Transcription Factor HSF1-Dependent Small Extracellular Vesicle Secretion Through Different Endosomal Stages
- Structural basis of stepwise G protein activation by the viral chemokine receptor US28
- Molecular crowding differentially regulates magnetic field-dependent fluorescence, recovery kinetics, and photostability of the magnetosensitive protein MagLOV2
- Thromboxane A2 receptor signalling amplifies osteoclastogenesis in rheumatoid arthritis through ACSL1 associated mitochondrial oxidative metabolism
- Circular RNA circINSR regulates bovine intramuscular adipocyte development and lipid accumulation through insulin receptor signaling
BibTeX
@article{bonef2026chemokine,
title = {{The chemokine receptor‐like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling}},
author = {Chloé Bonef and Hela Bouhsine and Carine Huynh and Marion Chaigneau and Steven Dubois and Mikel Garcia-Marcos and Catherine Llorens-Cortes and Denis Servent and Philippe Robin and Hervé Nozach and Isabel Alves and Xavier Iturrioz},
journal = {British Journal of Pharmacology},
year = {2026},
month = jul,
doi = {10.1111/bph.70558},
url = {https://hal.science/hal-05786854v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The chemokine receptor‐like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling
AU - Chloé Bonef
AU - Hela Bouhsine
AU - Carine Huynh
AU - Marion Chaigneau
AU - Steven Dubois
AU - Mikel Garcia-Marcos
AU - Catherine Llorens-Cortes
AU - Denis Servent
AU - Philippe Robin
AU - Hervé Nozach
AU - Isabel Alves
AU - Xavier Iturrioz
PY - 2026
DA - 2026/07/03
JO - British Journal of Pharmacology
DO - 10.1111/bph.70558
UR - https://hal.science/hal-05786854v1
AB - BACKGROUND AND PURPOSE: Apelin and Elabela are endogenous ligands of the apelin receptor (apelin receptor/APJ), a GPCR involved in cardiovascular regulation and body fluid homeostasis. The human receptor contains a conserved disulfide bridge linking the N-terminal domain to extracellular loop 3 (ECL3) via Cys19 and Cys281, forming a structural constraint analogous to a fourth extracellular loop ('ECL4'). In the chemokine receptor family, this motif plays a critical role in ligand engagement and receptor activation. EXPERIMENTAL APPROACH: The functional role of this disulfide bridge was investigated using site-directed mutagenesis (Cys19Ala and Cys281Ala), plasmon waveguide resonance binding assays and BRET-based biosensors to monitor Gαi activation and β-arrestin-2 recruitment. KEY RESULTS: Disruption of the disulfide bridge did not affect receptor surface expression but markedly impaired binding of apelin fragments (pE13F and K17F), leading to reduced Gαi signalling and β-arrestin-2 recruitment. In contrast, binding of the Elabela fragment K22P and the subsequent apelin receptor signalling activation were largely preserved. Antagonist antibodies (JN241 and JN241-Fc) retained activity, whereas the agonist antibody JN241-9-Fc showed strongly reduced efficacy for the mutated receptors. CONCLUSION AND IMPLICATIONS: The N-terminal/ECL3 disulfide bridge is a critical structural determinant for apelin binding and apelin receptor activation but is less critical for Elabela signalling, supporting distinct modes of ligand engagement. Antibody-mediated agonism is particularly sensitive to alterations of « ECL4 » without affecting its binding, suggesting that this structural constraint is required for optimal apelin receptor activation. The apelin receptor shares functional similarities with the chemokine receptors with respect to this.
SN - 0007-1188
SN - 1476-5381
ER -